Keywords
HyperglycemiaKetogenesisMetabolic acidosisKetonemiaKetonuriaDiabetic Ketoacidosis
In general, diabetic ketoacidosis (DKA) is the most common presentation in patients with type 1 diabetes. It is also common in patients with type 2 diabetes. DKA is an important acute cause of morbidity and mortality in these patients. Symptoms of DKA were observed before the discovery of insulin by Kussmaul as early as 1874. An association between DKA and coma was established by the 1880s. After the discovery of insulin in 1922, deaths due to DKA have dramatically decreased from 60% to <2%. DKA is a condition that is characterized by hyperglycemia (>250 mg/dL), ketonemia, ketonuria, and high anion gap (AG) metabolic acidosis. Hyperglycemia causes hyperosmolality and glucosuria. Both glucosuria and ketonuria cause massive urinary losses of water, Na+, K+, and phosphate. As a result, severe volume depletion and electrolyte losses occur in DKA.
Pathogenesis of DKA
Hyperglycemia
DKA is produced due to absolute or relative deficiency of insulin with concomitant increase in hormones that oppose the action of insulin. These are called counterregulatory hormones, which are glucagon, epinephrine, norepinephrine, cortisol, and growth hormone. Of these hormones, glucagon plays a major role in DKA. However, it should be noted that DKA does not generate without insulin deficiency or its resistance. Insulin deficiency and glucagon cause hyperglycemia by impaired peripheral glucose utilization, increased gluconeogenesis by the liver and kidney, and glycogenolysis. As stated above, hyperglycemia causes glucosuria with resultant volume depletion and prerenal azotemia.
Ketogenesis
Once acyl-CoA is in the mitochondrial matrix, it undergoes β-oxidation to yield acetyl-CoA. Two molecules of acetyl-CoA react to form acetoacetyl-CoA. Subsequently, another molecule of acetyl-CoA combines with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This reaction is catalyzed by HMG-CoA synthetase. The HMG-CoA is further cleaved into acetoacetate and acetyl-CoA by HMG-CoA lyase. Acetoacetate is subsequently reduced to β-hydroxybutyrate by the enzyme β-hydroxybutyrate dehydrogenase. This reaction is controlled by high NADH/NAD+ ratio (see Fig. 6.1). Among counterregulatory hormones, glucagon plays an important role in ketogenesis in diabetic patients. It has been reported that 1000–2000 mEq/L/day of ketones are formed in patients with severe diabetic ketoacidosis.
Ketogenesis is under the control of a substrate for fatty acid synthesis called malonyl-CoA. In fed state, fatty acid synthesis occurs because of high circulating levels of insulin. During this fatty acid synthesis, malonyl-CoA inhibits the enzyme CPT1. When insulin levels are deficient or low, the synthesis of malonyl-CoA decreases, and its level falls. As a result, the inhibitory effect of malonyl-CoA on CPT1 is removed. This facilitates the action of CPT1 so that acyl-CoA can combine with carnitine for entry into the mitochondrion. Thus, ketogenesis is regulated by malonyl-CoA.
In summary, ketones are formed in diabetes from elevated levels of FFAs released from triglycerides. Long-chain fatty acids must be activated before they enter liver mitochondria, where they undergo β-oxidation to form acetoacetate. Subsequently, acetoacetate is reduced to β-hydroxybutyrate. Also, acetoacetate undergoes spontaneous nonenzymatic decarboxylation to form acetone, which is removed by the lungs causing acetone breath in patients with DKA. The kidneys also excrete ketones until glomerular filtration rate (GFR) is decreased substantially.
Metabolic Acidosis
Metabolic acidosis results from excess production of acetoacetic acid and β-hydroxybutyric acid. Both these acids dissociate at body fluid pH to yield H+, which are buffered by HCO3 − ions. As a result, serum [HCO3 −] decreases, and a high AG metabolic acidosis develops. In uncomplicated DKA, the increase in serum AG above normal approximates the decrease in serum HCO3 − from normal levels of 24 mEq/L. In other words, the ⧍AG/⧍HCO3 − ratio is 1:1.
In mild DKA, the body volume is relatively preserved due to intake of fluids by the patient because of thirst. If the patients drink fruit juice which contains citrate, depletion of serum HCO3 − level may not decrease that much because of citrate conversion into HCO3 −. This results in mild AG metabolic acidosis. Also, the kidneys play an important role in maintaining mild acidosis by excreting large quantities of ketones. However, when the patient develops severe volume depletion, excretion of ketones is diminished with resultant accumulation of these ketones in the serum and development of very high AG metabolic acidosis. In severe acidosis, the serum HCO3 − level may diminish to as low as 5 mEq/L.
Besides ketones, the diabetic patients also generate other acids such as L-lactic acid. It was suggested that D-lactic acid also contributes to metabolic acidosis in DKA. Because of ketones, and L- as well as D-lactic acids, the patients develop a very high AG metabolic acidosis at presentation of severe DKA.
Ketonemia and Ketonuria
As stated above, ketones are generated and excreted by the kidneys until GFR is substantially reduced. In DKA, production of β-hydroxybutyrate is more than the production of acetoacetate. As stated above, the ketones are excreted if volume depletion is mild and GFR is near normal. Under these conditions, ketonemia is less than ketonuria. When volume depletion is severe and GFR is substantially decreased, excretion of ketones is decreased, and ketonemia predominates ketonuria.
Precipitating Factors
Precipitating factors for DKA
Factor | Comment |
---|---|
1. Noncompliance or poor adherence to insulin administration | Inadequate insulin initiates DKA |
2. Infection | Urinary tract infection, septicemia, and other infections demand additional insulin requirements |
3. First episode of DKA | Indicates new onset of type 1 diabetes mostly in children |
4. Other factors Myocardial infarction Acute pancreatitis Stress Consumption of fluids with high sugar content Stroke Intestinal obstruction | All of these conditions cause insulin resistance or higher insulin dose requirements |
5. Drugs Glucocorticoids Thiazide diuretics First and second generation antipsychotics | Raise glucose levels |
6. Sodium-glucose cotransporter-2 inhibitors | These drugs cause “euglycemic DKA” (see further discussion) |
Clinical Manifestations
History and physical examination, including precipitating factors of DKA, is extremely important. Initial presentation of patients with DKA is attributable to hyperglycemia such as polydipsia, polyuria, thirst, weight loss, nausea, and vomiting. Abdominal pain mimicking acute abdomen is also a common complaint, which is due to acidosis, and the pain is related to the severity of acidosis. This complaint should be differentiated from diabetic gastroparesis which does not improve after correction of acidosis, whereas abdominal pain does improve following correction of acidosis.
Signs include tachycardia, tachypnea, Kussmaul breathing (deep and frequent breathing), hypothermia, hypotension, and altered mental status. Stupor and coma are seen mostly in children. Altered mental status is usually attributed to acidosis and hyperosmolality.
On physical examination, the patients look ill and volume depleted. Acetone breath (fruity odor) is common. Hypotension with orthostatic blood pressure and orthostatic pulse changes suggest severe volume depletion.
Laboratory Findings
Laboratory findings in DKA
Lab value | Commonly observed value | Comment |
---|---|---|
WBC | Elevated up to 15 to 17000 | Due to stress, demargination, and elevated levels of cortisol and catecholamines |
Hgb, hematocrit | Elevated | Due to volume depletion |
Serum glucose | >250 mg/dL | Insulin deficiency/resistance |
Serum HCO3 − | <20 mEq/L | Low because of buffering ketone anions |
Serum and urine ketones | Positive | Reagent strips (Ketostix, Acetest) contain nitroprusside, which reacts with acetoacetate and acetone but not with β-hydroxybutyrate |
Serum Na+ | Usually <140 mEq/L | Depletion of body stores and due to high glucose levels |
Serum K+ | Usually >5.2 mEq/L | Due to volume depletion and movement from ICF to ECF compartment |
Serum Cl− | Usually normal | Depletion of body stores common |
Serum creatinine and BUN | Elevated | Due to volume depletion. Note that acetoacetate may falsely elevate creatinine levels |
Serum Ca2+ and Mg2+ | Usually low unless volume depleted | Mild depletion of body stores |
Serum phosphate | Usually low unless volume depleted | Severe depletion of body stores |
Diagnostic criteria for DKA
Lab value | Mild | Moderate | Severe |
---|---|---|---|
Serum glucose (mg/dL) | >250 | >250 | >250 |
Arterial pH | 7.25–7.30 | 7.00–7.24 | <7.00 |
Serum HCO3 − (mEq/L) | 15–18 | 10–15 | <10 |
Anion gap | >10 | >12 | >12 |
Serum ketones | Positive | Positive | Positive |
Urine ketones | Positive | Positive | Positive |
Mental status | Alert | Alert-drowsy | Stupor |